<?xml version="1.0" encoding="UTF-8"?>
<ref id="pone.0074027-Zeuzem1">
 <label>7</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Zeuzem</surname>
   <given-names>S</given-names>
  </name>, 
  <name>
   <surname>Buggisch</surname>
   <given-names>P</given-names>
  </name>, 
  <name>
   <surname>Agarwal</surname>
   <given-names>K</given-names>
  </name>, 
  <name>
   <surname>Marcellin</surname>
   <given-names>P</given-names>
  </name>, 
  <name>
   <surname>Sereni</surname>
   <given-names>D</given-names>
  </name>, 
  <etal>et al</etal> (
  <year>2012</year>) 
  <article-title>The protease inhibitor, GS-9256, and non-nucleoside polymerase inhibitor tegobuvir alone, with ribavirin, or pegylated interferon plus ribavirin in hepatitis C. Hepatology</article-title>. 
  <volume>55</volume>: 
  <fpage>749</fpage>â€“
  <lpage>758</lpage>
  <comment>doi:
   <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/hep.24744" xmlns:xlink="http://www.w3.org/1999/xlink">10.1002/hep.24744</ext-link>
  </comment>
 </mixed-citation>
</ref>
